It is a pharma private limited company based in Rohini New Delhi, Delhi, India, established in 2016.
2016 | Rohini New Delhi, Delhi, India | ActiveAdreno Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2016 in Rohini New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33100DL2016PTC305661. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Adreno Pharmacuticals Private Limited. It upholds a compliant status. Its leadership includes Prasenjit Nandi (Director), Kabita Roy (Director). Past directors included Subroto Kumar Ghosh, Kabita Roy. It holds ₹0.64 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. G-11, Ground Floor, Vardhman Ac Market C.S.C, Block-E, Sector-18, Rohini New De, Lhi, Rohini New Delhi, Delhi, 110089.
U33100DL2016PTC305661
305661
08 September 2016
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Adreno Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasenjit Nandi | Director | 08 Sep 2016 | Current |
| Kabita Roy | Director | 04 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adreno Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.18% increase. The company also saw a substantial improvement in profitability, with a 204.11% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Adreno Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹643,233.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2023 | Hdfc Bank Limited | ₹0.64 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Adreno Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Adreno Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adreno Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Adreno Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Adreno Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.64 M with Charge ID 100845775 was registered on 03 Nov 2023. was recorded as a recent event.
Progress on Kabita Roy was appointed as a Director was appointed as a Director on 04 Jun 2019 & has been associated with this company since 6 years 6 months . was documented.
Progress on Prasenjit Nandi was appointed as a Director was appointed as a Director on 08 Sep 2016 & has been associated with this company since 9 years 3 months . was documented.
Adreno Pharmaceuticals Private Limited was registered on 08 Sep 2016 with Roc Delhi & aged 9 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Adreno Pharmaceuticals Private Limited is U33100DL2016PTC305661.
Adreno Pharmaceuticals Private Limited is headquartered at Unit No. G-11, Ground Floor, Vardhman Ac Market C.S.C, Block-E, Sector-18, Rohini New De, Lhi, Rohini New Delhi, Delhi, 110089.
Adreno Pharmaceuticals Private Limited was incorporated on 08 September 2016.
The current directors of Adreno Pharmaceuticals Private Limited are
The primary industry of Adreno Pharmaceuticals Private Limited is Trade.
Adreno Pharmaceuticals Private Limited is unlisted.
The authorized capital of Adreno Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Adreno Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX